U.S., July 2 -- ClinicalTrials.gov registry received information related to the study (NCT07045454) titled 'A Study of MHB118C Injection in Patients With Advanced Solid Tumors' on June 22.
Brief Summary: This is a first-in-human, open-label, multicenter Phase I study of MHB118C in patients with advanced solid tumors. The study was designed to evaluate the safety, tolerability, pharmacokinetics (PK), and preliminary efficacy of MHB118C monotherapy.
Study Start Date: March 31
Study Type: INTERVENTIONAL
Condition:
Advanced Malignant Solid Tumor
Intervention:
DRUG: MHB118C for Injection
IV administration by Q3W; Participants will continue treatment until the end of the study in the absence of unacceptable toxicities and confirmed diseas...